QA: Cellectar Biosciences Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2017_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc

  xvar xval
0 AssetsCurrent 12,193,188
1 IntangibleAssetsNetIncludingGoodwill 1,675,462
2 PropertyPlantAndEquipmentNet 1,444,058
3 remainder_Assets 11,872
4 LiabilitiesCurrent 1,632,876
5 LiabilitiesNoncurrent 151,832
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,259,846
9 ResearchAndDevelopmentExpense 4,895,027
10 remainder_Expenses 109,392
11 remainder_Revenues 0
12 remainder_NetIncome 3,270,622
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,324,580
1 Liabilities 1,784,708
2 Expenses 9,264,265
3 Revenues 0
4 StockholdersEquity 13,539,872
5 NetIncome -5,993,643
6 ComprehensiveNetIncome -5,993,643
7 BaseVar 14,822,088
8 EconomicCapitalRatiobeforeLimitedLiability 2.75
9 EconomicCapitalRatio 3.52

Edgar->Model Mapping

Feature Distribution

Change over Time